Publications by authors named "Jessica D Johnson"

Claim this Profile
T
The Discovery and Characterization of HBS-101, a Novel Inhibitor of Midkine, as a Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer.
Megharani Mahajan, Alondra L Rodriguez Sanchez, Sridharan Jayamohan, Dileep K Vijayan, Jessica D Johnson

Mol Cancer Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KDM1A/LSD1 inhibition enhances chemotherapy response in ovarian cancer.
Yihong Chen, Jessica D Johnson, Sridharan Jayamohan, Yi He, Prabhakar P Venkata

Mol Carcinog· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysine-specific demethylase 1 as a therapeutic cancer target: observations from preclinical study.
Jessica D Johnson, Salvador Alejo, Sridharan Jayamohan, Gangadhara R Sareddy

Expert Opin Ther Targets· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer.
Prabhakar Pitta Venkata, Sridharan Jayamohan, Yi He, Salvador Alejo, Jessica D Johnson

Cancer Lett· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastoma.
Salvador Alejo, Bridgitte E Palacios, Prabhakar Pitta Venkata, Yi He, Wenjing Li, Jessica D Johnson

Neuro Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reticulocalbin 3 Is a Novel Mediator of Glioblastoma Progression.
Yi He, Salvador Alejo, Jessica D Johnson, Sridharan Jayamohan, Gangadhara R Sareddy

Cancers (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Targeting of Ovarian Cancer Stem Cells Using Estrogen Receptor Beta Agonist.
Yi He, Salvador Alejo, Prabhakar Pitta Venkata, Jessica D Johnson, Ilanna Loeffel

Int J Mol Sci· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis